Skp2 is required for incretin hormone-mediated β-cell proliferation.
Mol Endocrinol · 2011
Last updated 2026-05-28A study found that a protein called Skp2 is necessary for GLP-1 and its analog exendin-4 to stimulate the growth of insulin-producing beta cells. In lab tests, GLP-1 increased Skp2 levels, which helped break down another protein (p27) linked to cell growth. However, in mice and human tissue samples, aging reduced p27 levels but prevented beta-cell growth due to another protein (p16) blocking the effect.
AI summary of the abstract below.
| Journal | Mol Endocrinol, 2011 |
|---|---|
| Citations | 29 |
| Relative citation ratio | 0.69 |
| NIH percentile | 38 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
The glucoincretin hormone glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (Ex-4) promote β-cell growth and expansion. Here we report an essential role for Skp2, a substrate recognition component of SCF (Skp, Cullin, F-box) ubiquitin ligase, in promoting glucoincretin-induced β-cell proliferation by regulating the cellular abundance of p27. In vitro, GLP-1 treatment increases Skp2 levels, which accelerates p27 degradation, whereas in vivo, loss of Skp2 prevents glucoincretin-induced β-cell proliferation. Using inhibitors of phosphatidylinositol 3-kinase and Irs2 silencing RNA, we also show that the effects of GLP-1 in facilitating Skp2-dependent p27 degradation are mediated via the Irs2-phosphatidylinositol-3 kinase pathway. Finally, we show that down-regulation of p27 occurs in islets from aged mice and humans, although in these islets, age-dependent accumulation of p16(Ink4a) prevent glucoincretin-induced β-cell proliferation; however, ductal cell proliferation is maintained. Taken together, these data highlight a critical role for Skp2 in glucoincretin-induced β-cell proliferation.
Verbatim abstract via PubMed 21980072 ↗